Versuchen GOLD - Frei

BioSpectrum Asia - BioSpectrum Asia April 2025

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Lesen BioSpectrum Asia zusammen mit über 9.000 anderen Zeitschriften und Zeitungen mit nur einem Abonnement

Katalog anzeigen

1 Monat

$14.99

1 Jahr $149.99

$149.99

$12/month

(OR)

Abonnieren Sie nur BioSpectrum Asia

Geschenk BioSpectrum Asia

Jederzeit kündbar.

(Keine Verpflichtungen) ⓘ

Sollten Sie mit Ihrem Abonnement nicht zufrieden sein, senden Sie uns innerhalb von 7 Tagen nach Abonnementbeginn eine E-Mail an help@magzter.com, um eine vollständige Rückerstattung zu erhalten. Versprochen! (Hinweis: Gilt nicht für den Kauf einzelner Ausgaben.)

Digitales Abonnement

Sofortiger Zugriff ⓘ

Abonnieren Sie jetzt, um sofort mit dem Lesen auf der Magzter-Website sowie in den iOS-, Android- und Amazon-Apps zu beginnen.

Verifiziert sicher

zahlen ⓘ

Magzter ist ein verifizierter Authorize.Net-Händler. Weitere Informationen

In dieser Ausgabe

CDMOs Clean Up Act: Environmental Responsibility Sustainability is no longer a buzzword in the background, but has become critical as the pharmaceutical industry faces evolving regulations and growing environmental concerns. Manufacturing, which accounts for approximately 80 per cent of a pharmaceutical company's indirect emissions, is now a key focus in the push toward more sustainable practices. With mounting pressure to reduce carbon footprint, contract development and manufacturing organisations (CDMOs) companies are ramping up the integration of green technologies into their manufacturing processes.

THE DRAGON ATTRACTS BIG PHARMA, BIG BUCKS

Multi-national pharma giant AstraZeneca's recent announcement to set up a global strategic R&D centre in Beijing is significant in multiple ways.

2 mins

New Zealand launches strategic approach to immunisation for next 5 years

The Health Ministry in New Zealand has launched a Strategic Approach to Immunisation 2025-2030 to provide a renewed vision and strategic direction for the immunisation system for the next five years.

1 mins

Australia approves first and only treatment for chronic hypoparathyroidism

Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has received the registration of YORVIPATH (palopegteriparatide) by the Therapeutic Goods Administration (TGA), for the treatment of chronic hypoparathyroidism in adults.

1 mins

Singapore announces expansion of healthcare capacity

The Ministry of Health (MOH) in Singapore plans to continue to transform and strengthen its healthcare workforce, in tandem with capacity expansion.

1 mins

Indonesia and Saudi Arabia sign MoU to strengthen human resources within healthcare sector

Indonesian Health Minister Budi Gunadi Sadikin and Saudi Arabian Health Minister Fahd Abdulrahman Al-Jalajel have formalised a Memorandum of Understanding (MoU) aimed at enhancing human resource (HR) capacity of the healthcare sector through exchanges and training, as well as facilitating the exchange of digital vaccine certificates.

1 mins

Avecho and Sandoz announce $16 M deal to commercialise CBD for insomnia treatment in Australia

Avecho Biotechnology has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG for the commercial rights to Avecho's Phase III cannabidiol (CBD) capsule for insomnia in Australia.

1 mins

FibroGen sells China biz to AstraZeneca for $160 M

FibroGen, Inc. has announced the sale of its China subsidiary to AstraZeneca for approximately $160 million.

1 mins

Samsung invests $10 M in US-based C2N Diagnostics to strengthen brain healthcare

US-based C2N Diagnostics, LLC, a specialty diagnostics company with a vision to bring Clarity Through Innovation, has announced a $10 million investment from Korea's Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment Corporation.

1 mins

Sun Pharma buys Checkpoint Therapeutics for $255 M

India-based Sun Pharmaceutical Industries Limited and US-based Checkpoint Therapeutics, Inc. have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company.

1 mins

Boehringer Ingelheim enhances biopharma contract manufacturing services in China

Boehringer Ingelheim's biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a regulatory reform promoting segmented manufacturing of biological products by the local authorities.

1 mins

Astellas and Yaskawa to establish joint venture in Japan focused on cell therapy manufacturing

Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement to establish a joint venture for the development of a cell therapy product manufacturing platform utilising the dual-arm robot 'Maholo'.

1 mins

Biocon Biologics and Civica collaborate to expand insulin Aspart access in US

Bengaluru-based Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, and Civica, Inc., a not-for-profit generic drug and pharmaceutical company founded in 2018 to address and resolve life-saving drug shortages and affordability, have announced a strategic collaboration agreement to expand access and affordability of Insulin Aspart in the United States (US).

1 mins

Indaptus Therapeutics extends patent portfolio in China, Japan, and Israel

US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its Decoy platform.

1 mins

Docquity introduces AI-powered medical resource platform in Indonesia

Docquity, a leading healthtech company in Southeast Asia, and Rumah Sakit Umum Daerah (RSUD) Umar Wirahadikusumah Sumedang, a regional hospital in West Java, Indonesia, have announced a partnership to integrate Dx, Docquity's artificial intelligence (AI)-powered medical resource platform, into the hospital's medical reference system.

1 mins

Lunit expands partnership with Saudi Arabia's largest medical group to deploy AI chest X-ray solution

South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has announced a second agreement with Cloud Solutions, a subsidiary of Dr. Sulaiman AI Habib Medical Group (HMG), Saudi Arabia's largest medical organisation.

1 mins

Callio Therapeutics launches with $187 M Series A round to advance multi-payload ADC platform

Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, has announced its launch with the closing of a $187 million Series A financing round.

1 mins

Insilico Medicine secures $110 M Series E financing to advance Al-driven drug discovery innovation

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery startup headquartered in Hong Kong, has successfully secured a $110 million Series E financing led by a private equity fund of Value Partners Group, one of Asia's largest independent asset management firms, with strong participation from industry- and technology-focused new investors, as well as continued support from global existing backers.

1 mins

Call for collective action to address rising global burden of chronic diseases

The global pharmaceutical industry has issued a \"Call to Action\" urging collective action across the globe to tackle the rise of non-communicable diseases (NCDs) such as cancer, diabetes, cardiovascular disease, lung disease, mental health, and neurological disorders.

1 mins

9 Latin American & Caribbean countries intensify efforts to curb obesity

The Pan American Health Organization (PAHO) is working on a project with nine countries of the Americas on an initiative to strengthen actions against obesity in the region, which has the highest prevalence of overweight and obesity in the world.

1 mins

CDMOS Clean Up Act: Environmental Responsibility

Sustainability is no longer a buzzword in the background, but has become critical as the pharmaceutical industry faces evolving regulations and growing environmental concerns.

10+ mins

Advancing Green Pharmaceuticals: Sustainable Biomanufacturing Practices Across APAC

The pharmaceutical industry is at a critical juncture, urgently needing to transform towards sustainability to reduce its environmental footprint.

7 mins

Trump's tariff war threatens to disrupt pharma supply chain

After pulling US funding from the World Health Organisation (WHO), the US President Donald Trump has now announced a 25 per cent tariff on pharmaceutical imports. With countries like India and China being major suppliers to the U.S. market, this move raises serious concerns about the future of drug prices, supply chains, etc. Let's analyse how this could impact the global pharmaceutical industry.

4 mins

Healing an Ailing MedTech Talent Ecosystem

The Asia-Pacific (APAC) region represents a critical landscape for the future of medical technology. However, a thriving medical technology sector needs people skilled in engineering, product development and manufacturing. With advances in artificial intelligence (AI) and robotic surgeries driving a big transformation and creating new opportunities, it is also deepening the skills gap many workers face. Let's take a closer look at these gaps and the solutions that are emerging to address those gaps.

7 mins

"AI will shift the focus of healthcare professionals toward higher-value tasks like clinical decision-making"

Australian AI-powered medical imaging company, Harrison.ai, has secured $112 million in Series C funding to accelerate product development, expand clinical partnerships, and scale its global presence.

4 mins

"There are over 650 cell and gene therapy clinical trials underway in APAC region"

Catering to pharma companies globally and ensuring seamless transportation of critical healthcare products, World Courier, a global specialty logistics provider and a part of US-based contract research organisation Cencora, has recently appointed Michael Culme-Seymour as its new Regional Vice President for Asia Pacific (APAC).

5 mins

"Affordability remains a big concern for Indian ophthalmology market"

Currently, India faces a growing eye-health concern with approximately 4.95 million blind persons and 70 million vision-impaired individuals, including 240,000 blind children.

4 mins

"Biggest challenge in running a chronic Hepatitis B trial is often patient recruitment"

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released its latest disease report: Hepatitis B - Global Clinical Trial Landscape (2025) in March 2025.

5 mins

"ADCS have already become a mainstay treatment option across a variety of both hematologic and solid cancers"

The resurgence of antibody-drug conjugates (ADCs) in cancer therapy signifies a shift towards targeted, highly effective treatments, leveraging the power of monoclonal antibodies to deliver potent cytotoxic payloads directly to cancer cells, minimising harm to healthy tissues.

5 mins

"Encephalitis is associated with significant costs to individuals and society, due to its high morbidity and mortality"

World Health Organization (WHO) and United Kingdom-headquartered Encephalitis International launched a critical Technical Brief on Encephalitis in London on February 20 as World Encephalitis Day celebrated on February 22 every year.

2 mins

PolyU and Peking University explore collaboration in medical technology in China

The Hong Kong Polytechnic University (PolyU) and Peking University Health Science Center (Peking University) have signed a Memorandum of Understanding (MoU) to explore collaboration in the field of medical technology, including joint research and faculty and student exchanges.

1 mins

Vydehi Institute of Medical Sciences and Research Centre in India to expand access to robotic-assisted surgery

Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, a leading institution in multi-specialty tertiary care in India, has joined hands with Intuitive, a global technology leader in minimally invasive care and the pioneer of roboticassisted surgery (RAS), to introduce resident surgeons to robotic-assisted surgical technology through the Intuitive Robotic Onboarding Programme and Education (I-ROPE).

1 mins

Michael D. Patten steps in as Chief Strategy Officer of Harbour BioMed

Harbour BioMed, a US and China-based biopharmaceutical company, has announced the appointment of Michael D. Patten as Chief Strategy Officer.

1 mins

SuperFreeze appoints Troy Shortell as Co-CEO to drive innovation across Asia

SuperFreeze, an operator, developer, and owner of advanced cold storage facilities in Asia, has announced the appointment of Troy Shortell as Co-CEO.

1 mins

Lunit announces leadership transition at Volpara, Craig Hadfield steps in as CEO

South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has announced the appointment of Craig Hadfield as the new Chief Executive Officer (CEO) of its subsidiary, Volpara Health Technologies.

1 mins

GE HealthCare names new president and CEO for China biz

GE HealthCare (GEHC), a leading global healthcare solutions provider, has announced that Yihao Zhang, president and Chief Executive Officer (CEO), China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare's new president and CEO, China, is joining the company on April 1, 2025, ahead of leading the region starting July 1 following Yihao's departure.

1 mins

Korea develops advanced AI model for accelerating therapeutic gene target discovery

Identifying therapeutic gene targets is essential for advancing personalised medicine and addressing the genetic basis of diseases.

1 mins

CEPI funds Nagasaki University's 'Nanoball' technology to help defeat Disease X

A new 'nanoball' vaccine platform developed by experts in Japan will be tested as part of new research, supported by Norway-based Coalition for Epidemic Preparedness Innovations (CEPI), looking for promising tools that could help fight an infectious disease outbreak with pandemic potential.

1 mins

India builds AI-powered model to improve blood sugar predictions for diabetes management

A research team at National Institute of Technology (NIT) Rourkela, India has developed a new artificial intelligence (AI)driven approach to improve blood sugar predictions for people with diabetes.

1 mins

Thailand designs exoskeleton wheelchair to aid mobility

Thailand's Chulalongkorn University has introduced the Exoskeleton Wheelchair, an innovative robotic suit designed to help people with disabilities stand, walk, and move more independently.

1 mins

Bruker introduces X4 POSEIDON advanced X-ray microscope for scientific applications

American manufacturer of scientific instruments Bruker Corporation has announced the launch of the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using micro Computed Tomography (microCT).

1 mins

Parse Biosciences plans to release single cell chromatin accessibility products

The US-based Parse Biosciences, the leader in accessible and scalable single cell sequencing, has affirmed plans to proceed with development and future release of their Evercode single cell chromatin products.

1 mins

PerkinElmer acquires Project Farma to expand services for life sciences industry

PerkinElmer, a global leader in analytical solutions and specialised services for biopharma, applied and food markets, has announced the acquisition of Project Farma, a subsidiary of Precision for Medicine.

1 mins

Sunflower Therapeutics announces commercial launch of Daisy Petal Perfusion Bioreactor System in Asia

US-based Sunflower Therapeutics has announced its first distribution agreement with PharmNXT Biotech, an Indian bioprocessing company.

1 mins

Lesen Sie alle Geschichten von BioSpectrum Asia

BioSpectrum Asia Description:

Herausgeber: MM-Activ-Sci-Tech-Communication

Kategorie: Business

Sprache: English

Frequenz: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.

* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.

* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.

* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.

* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.